Tag Archives: Nephrogenic Fibrosing Dermopathy
-
-
Nephrogenic Systemic Fibrosis Lawsuit Scheduled For Trial in San Francisco
-
Nephrogenic Systemic Fibrosis Risk 77 Times Higher Among Dialysis Patients
-
Optimark MRI Contrast Agent NSF Warning Updated
-
Nephrogenic Systemic Fibrosis Warnings to be Reviewed Again by FDA
-
Gadolinium MRA Contrast Agent Approved by FDA with Warnings about Nephrogenic Systemic Fibrosis
-
Gadolinium Lawyers to Select from 193 NSF Lawsuits for First Trials
-
Gadolinium Lawyers Set to Meet with Court about Product Identification and Trial Selection
-
Gadolinium Litigation Involves 391 Lawsuits in State and Federal Court
-
Nephrogenic Systemic Fibrosis Lawsuit